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Rat brain phospholipids were labelled in vivo by an intraventricular injection of 32P. The radioactivity was found 
to accumulate predominantly in limbic structures, particularly hippocampus and diencephalon. A rapid and high 
specific labelling of the inositol phospholipids and phosphatidic acid was observed. The rate of incorporation into 
a crude myelin fraction was similar to that into a mitochondrial/synaptosomal fraction although phosphatidyl- 
myo-inositol 4,5diphosphate was especially enriched in myelin. Upon incubation in vitro of the brain fractions 
after 2 h p~~be~~ in vivo, both pho~hatidyl~~o-~ositol 4-phosphate and phosphat~yl~yo-~ositol 4,5- 
diphosphate rapidly lost their ~dioacti~~. Half of the labile fraction of the incorporated 32P was removed 
within 2 min. None of the other phospholipids changed in the 30 min in vitro incubation period. The metabolism 
of the polyphosphoinositide proceeded at a lower rate when the temperature was lowered, and was Ca”depen- 
dent. Further subcellular fractionation revealed that purified synaptosomes and myelm contained highly labelled 
phosphatidyl+rzyo-mositol 4,5diphosphate. Mitochondria contained highly labelled phosphatidyl-myo-inositol 
but no phosphatidylmyo-inositol4-phosphate or phosphatidyl-myoGnositol4,Sdiphosphate. ACTH1.24 did not 
inhibit the in vitro dephospho~lation of prelabelled polyphospho~ositide, confvming previous findings that the 
peptide affects the pol~ho~ho~o~tide kinases and not the respective phosphate. 
Introduction 
The inositol phosphoiipids have been implicated in 
the regulation of membrane permeabihty and synap 
tic transmission in neurons [l ,2) . An enhanced me- 
tabolism of phosphatidyiinositoi was observed in vari- 
ous tissues after receptor activation by hormones and 
neurotransmitters that utilize Ca2’ as their intraceilu- 
lar second messenger [l] . Jts phosphoryiated deriva- 
tives (phosphatidyiinositol 4-phosphate, phospha- 
tidylinositoI4,5-diphosphate) are quantitatively minor 
membrane components in most mammalian tissues, 
but reiativeIy high concentrations of phosphatidyi- 
Abbreviations: EGTA, ethylene glycol bis@aminoethyI 
ether)NN-tetraacetic acid; ACTH, adrenocorticotropin. 
myo-inositol 4-phosphate and phosphatidyl-myo-ino- 
sitoi 4,Sdiphosphate are found in nervous tissue [2]. 
The brain poiyphosphoinositides are principally com- 
ponents of the myelin sheath or a contiguous struc- 
ture, but a metabolically very active pool of poly- 
phosphoinositide is present at non-myeiin sites [3,4], 
presumably at synaptosomai or giiai plasma mem- 
branes, The very rapid turnover of their monoesteri- 
tied phosphate group [5] suggests that they have an 
important physiological role. They are implicated in 
the metabolism of Ca2+ at the ceI1 membrane and 
their breakdown has been observed after the influx of 
this ion into the cell [6-8’J. 
It has been found recently that the metabolism of 
phosphatidyi-myo-inositoi 4,5-diphosphate, phospha- 
tidyl-myo-inositol 4-phosphate and phosphatidic acid 
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is influenced by neuropeptides derived from ACTH 
[9] and by /3-endorphin [lo]. These peptide effects 
were obtained in a lysed membrane fraction from rat 
brain that was incubated for a short period (10 s) 
with [T-~~P]ATP. Similar findings were done in puri- 
fied phosphatidyl-myo-inositol 4-phosphate kinase 
preparations [ 10,111. Furthermore, it appeared that 
ACTH acted on the lipid kinases and not on the 
respective phosphatases [9]. These findings prompted 
us to study the influence of ACTH and Ca2+ on the 
metabolism of phosphatidyl-myo-inositol 4-phos- 
phate and phosphatidyl-myo-inositol4,5-diphosphate 
in situations in which only radioactive dephosphory- 
lation can be monitored. 
We report here experiments in which the metab- 
olism of these lipids was studied in vitro after pre- 
labelling of the rat brain in vivo. 
Materials and Methods 
Animals and brain dissection 
Male rat (150 g) of an inbred Wistar strain were 
used (TNO, Zeist, The Netherlands). They were sup- 
plied with a permanent brain cannula ending in the 
interventricular foramen [ 121. After 1 week of recov- 
ery they received an intracerebroventricular injection 
of 3 cl1 saline containing 50 PCi 32Pi (carrier-free, 
type NEX-054, New England Nuclear, Boston, MA, 
U.S.A.). The in vivo labelling period was 2 h unless 
stated otherwise. The rats were killed after this time 
interval by whole body immersion into liquid nitro- 
gen for 8 s, followed by rapid dissection of the cold 
but not frozen brain at 0-4°C. The limbic system 
(hippocampus, septum, basal ganglia, pyriform cor- 
tex, diencephalon, mesencephalon) was dissected as 
described previously [ 131. 
Subcellular fractionation 
The dissected material from one rat (0.3 g) was 
homogenized in 10 ml 0.32 M sucrose by 10 up-and- 
down strokes of a Potter-Elvehjem teflon glass homo- 
genizer with a radial clearance of 0.125 mm, rotating 
at 700 rev./min. The subcellular fractionation was 
based on the method of Gray and Whittaker [14]. 
Briefly, the homogenate was spun for 5 min at 
700 X g (Sorvall SS34). After centrifugation of the 
supernatant for 10 min at 1000 Xg the pellet was 
taken as the crude myelin fraction. The supernatant 
was spun for 10 min at 10 000 X g and the resulting 
pellet (P2) was taken as the crude mitochondrial/ 
synaptosomal fraction. 
Purified synaptosomes and mitochondria were 
prepared according to the method of Booth and Clark 
[15]. Briefly, the dissected material from one rat 
(0.3 g) was homogenized in 10 vol. isolation medium 
(0.32 M sucrose/l mM EDTA/lO mM Tris-HCl, pH 
7.4). The homogenate was diluted to 10 ml with iso- 
lation medium and centrifuged at 1300 X g for 3 min. 
The supernatant was collected and after centrifuga- 
tion at 17 000 X g for 10 min the resulting pellet was 
resuspended in 1.5 ml isolation medium. This suspen- 
sion was diluted to 9 ml with 12% Ficoll/sucrose 
medium (12% (w/w) Fico11/0.32 M sucrose/50 /.&I 
EDTA, pH 7.4) and gently homogenized by hand in a 
Potter-Elvehjem teflon glass homogenizer with a 
radial clearance of 0.375 mm. This suspension was 
introduced into a centrifuge tube and above this 4.5 
ml of a 7.5% Ficoll/sucrose medium was layered 
(7.5% (w/w) Fico11/0.32 M sucrose/50 PM EDTA, pH 
7.4). Finally, on top of this 7.5% medium, 3.5 ml of 
isolation medium was layered. The tubes were centrif- 
uged at 100 000 X g for 30 min (a Beckman SW 27.1 
rotor in a Sorvall OTD-2 ultracentrifuge). Myelin and 
synaptosomes banded at the first and second inter- 
phase, respectively, with the free mitochondria being 
pelleted at the bottom [ 151. The fractions were care- 
fully removed by suction with a Pasteur’s pipette and 
diluted with isolation medium to 10 ml. After cen- 
trifugation for 10 min at 10 000 X g the pellets were 
taken up in incubation medium in a final volume of 
10 ml. In enzyme contamination studies [ 151 it was 
found that these synaptosomes are contaminated by 
‘free’ mitochondria on a protein basis by l-4%; they 
have a free membrane contamination below 1%. 
Lipids from the various subcellular fractions were 
provisionally identified by two-dimensional thin-layer 
chromatography [ 161. The presence of cerebrosides 
and sulphatides was taken as a measure of myelin 
contamination. Protein was determined according to 
the method of Lowry et al. [ 171. 
Incubation in vitro 
The in vitro metabolism of 32P-labelled phospho- 
lipids was assayed in incubation medium [18] con- 
taining (final concentrations): 124 mM NaCl, 5 mM 
KCl, 1.2 mM KHaPOa, 1.3 mM MgC12, 0.75 mM 
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CaC12, 1.6 mM cytidine, 1.6 mM myo-inositol, 10 
mM glucose, 20 n&l Tris-HCI, pH 7.4, in a final 
volume of 25 1.11 at 37°C unless stated otherwise. The 
fractions obtained by subcellular fractionation were 
suspended in incubation buffer and kept at 0°C. Pre- 
incubation with synthetic ACTH1_24 (Organon Oss 
Int. BV, Oss, The Netherlands) was performed for 
5 min. The incubation was started by placing the 
incubation vessel in a water bath at the indicated tem- 
perature and was terminated by the addition of 2 ml 
ice-cold chloroform/methanol/l3 M HCI (200 : 100 : 
0.75,byvol) [19]. 
Lipid extraction and thin-layer chromatography 
The procedure used is described in detail elsewhere 
[9]. Briefly, carrier polyphosphoinositides were 
added, and a biphasic system was obtained by the 
addition of 0.375 ml 0.6 M HCl. The upper phase was 
removed and the lower phase washed with 1 ml chlo- 
roform/methanol/0.6 M HCl (3 : 48 : 47, by vol). 
The resulting lower phase was dried under Ns and 
redissolved in chloroform/methanol/water (75 : 25 : 
2, by vol). Samples were taken for the determination 
of radioactivity incorporated into total phospholip- 
ids. 
Phospholipids were separated by high-performance 
thin-layer chromatography (HPTLC;layer thickness 25 
pm, Merck). Before use, the plates were impregnated 
with potassium oxalate as described [9] and activated 
for 15 min at 110°C. The extract was applied to the 
plate and the lipids were separated with chloroform/ 
acetone/methanol/glacial acetic acid/water (40 : 15 : 
13 : 12 : 8, by vol). On each plate 18 samples were 
run simultaneously. This procedure yielded quantita- 
tive separation of labelled lipids. They were visualized 
with iodine vapour and 32P-labelled spots were 
detected by autoradiography on Kodak Royal 
X-Omat film (1 O-20 h). The spots were scraped from 
the plate and counted for radioactivity in a liquid 
scintillation spectrometer [9]. All operations (lipid 
prelabelling in vivo, subcellular fractionation, incuba- 
tion, lipid extraction and thin-layer chromatography) 
were performed on the same day. 
Results 
The distribution of radioactivity over the brain after 
intracerebroven tricular injection: time curve 
To determine the distribution of injected [“‘PI- 
orthophosphate at different time periods after the 
intracerebroventricular injection, five groups of ani- 
mals were used. They were killed at 0.25, 0.5, 1, 2 
and 4 h after the injection, and the total amount of 
label in the dissected brain parts was determined. The 
right hippocampus, right neocortex and the dience- 
phalon contained the major part of the recovered 
radioactivity. The relative contribution of limbic 
structures (especially hippocampus) increased with 
increasing labelling time (data not shown). The struc- 
tures from the right hemisphere contained more label 
than those from the left hemisphere, as was to be 
expected in view of the placement of the cannula 
above the right hemisphere [ 121. 
In vivo incorporation of 32P into individual phospho- 
lipids: time curve 
In view of the data presented in the previous sec- 
tion and in previous studies on polyphosphoinositide 
metabolism [9,20], the limbic system was chosen for 
further study. In view of the reported high metabolic 
activity of phosphatidyl-myo-inositol 4-phosphate 
and phosphatidyl-myo-inositol 4,5-diphosphate [5] 
care was taken to avoid postmortem breakdown of 
these lipids. Control experiments showed that no loss 
of incorporated radioactivity occurred during the dis- 
section of the cold but not frozen brain at 0-4°C. In 
these experiments, whole brain was taken out from 
the skull after immersion of the animal in liquid 
nitrogen. The brain was either immediately extracted 
with acidified chloroform/methanol as described 
(Materials and Methods) or after 1, 5 or 10 min at 
0-4°C. There were no differences in amounts and 
ratios of radioactively labelled phospholipids. Fur- 
thermore, no breakdown of labelled lipid took place 
during homogenisation and subcellular fractionation 
(data not shown; see also Fig. 3). 
The in vivo incorporation of 32P into the different 
lipid classes was assessed in a synaptosomal/mito- 
chondrial fraction (P2 fraction) and in a crude myelin 
fraction. Various in vivo labelling periods were com- 
pared (0.5, 1, 2, 4 h). The inositol lipids and phos- 
phatidic acid were labelled very rapidly (Fig. 1): these 
lipids contained 85-90s of the incorporated radio- 
activity after 30 min. The contribution of other phos- 
pholipids (particularly phosphatidylglycerol, cardio- 
lipin, phosphatidylethanolamine and phosphatidyl- 
choline) increased with increasing incubation time. 
b 
timelhaursl 
Fig. 1. Time curve of the in vivo incorporation of 32P into 
individual phospholipids. Pour groups of rats were taken. The 
animals received an intracerebroventricular injection of 32Pi 
and were killed after 0.5, 1, 2 or 4 h. The limbic system was 
dissected; a crude mitochondrial/synaptosomal fraction (P2; 
Fig. la) and a crude my&n fraction (Fig. lb) were obtained. 
The radioactive incorporation into membrane-phospho~pids 
was determined as described. The incorporation of label into 
individual phospho~pids is expressed as a percentage of the 
radioactivity in~rporat~ into total phospho~~~ds f2l] to 
reduce variation due 10 differences in injection efficiency. 
This variation was manifest in the total amount of incorpora- 
tion but not in the incorporation pattern. The mean of two 
different experiments (H = 4) is given. 0) Phosphatidyl-myo- 
inositol; *, phosphatidyl-myo-inositol 4-phosphate; o, phos- 
phatidylmyo-inositol 4Jdiphosphate; 0, phosphatidic acid; 
0. rest. 
These lipids contained 32% of the incorporated 32P 
after a 4 h fabelhng period, and these values increased 
to 85% after 1 day (data not shown). 
Although the absolute amount of in~o~oration 
was similar in both sub~e~ular fractions, the incorpo- 
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ration pattern was different: the ratio of 32P-labelled 
phosphat~dyl-dye-inositol 4~~-diphosphate over 32P- 
labelled phosphatidyl-~~~-~nositol was about 2 in 
crude my&n, and 0.6-0.8 in the P2 fraction. On the 
basis of these data we decided to use a 2 h labelling 
period for further study, thus compromising the need 
for a high specific labelling of the phosphatidylwmyo- 
inositol, phosphatidylmyo-inositol 4-phosphate, 
phosphatidylmyo-inositol 4,Sdiphosphate and phos- 
phatidic acid, with a sufficient amount of incorpora- 
tion. 
&r V&G rne~~~~~~srn of~re~~e~~ed ~~os~~~~~~~d~ 
A P2 fraction and a crude myelin fraction were ob- 
tained as described (see Materials and Methods) and 
suspended in the incubation medium described by 
Bradford (lpi]. The suspensions were incubated for a 
period of time ranging from 15 to 30 min, and the 
radioactivity in the individual phospholipids was 
determined. It appeared that the amount of radioac- 
tively labelled phosphatidyl-myo-inositol 4-phosphate 
and phosphatidyl-rny~-~nositol 4,5diphosphate 
decreased rapidly with incubation time. The radioac- 
tivity recovered from phosp~tidyi-~~~~-i~ositol 
4-phosphate and phosphatidy~-~~~-inositol 4,Sdi- 
phosphate reached an asymptote at 50 and 35% of 
the original level, respectively (Fig. 2). Half of this 
labile 32P was removed within 2 min after the start of 
the incubation. Phosphatidyl-myo-inositol, phuspha- 
tidic acid and the other phospholipids were not 
changed in the 30 min incubation period. The results 
obtained with both subcellular fractions were similar. 
When the P2 fraction was incubated at lower tem- 
perature to slow down the enzymic activity, it 
appeared that a significant dephosphorylat~on of 
phosphatidyl-~yo-inositol 4-phosphate and phospha- 
~dyl-rn~~~inosi~o~ 4,5-diphosphate occurred at 30,24 
and 18’C, but no breakdown was found at 0°C 
(Fig. 3). 
The influerrce of extracellular c?I’* and ACTHS_24 on 
the dephosphorylation of phosphatidyl-myo-lnnnsitol 
4-phosphate and phosphatidyl-myo-inositol 4,$-d& 
phosphate 
in view of the important role played by Ca” in 
the metabolism of phosphatidyl-rn~~-inositol 4-phos- 
phate and p~osphatidyl~~~-inos~tol4,5.diphosphate 
fS---79j it was decided to test the dephospharylation 
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180 
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mcubation min) 
Fig, 2. In vitro dephosphoryiation of polyphosphoinositide 
after prelabelling in vivo. Brain phospholipids were IabeIled in 
vivo for 2 h. Subcellular fractions were obtained and incu- 
bated in vitro (37°C) for varying periods of time. The results 
are expressed in dpm per fig incubated protein. a, P2 frac- 
tion; b, crude myelin fraction. o, Phosphatidy~~yu-~nositol 
A, phosp~tidyi~y~-inositol 4-phosphate; o, phosphatidyl- 
myo-inositol4,Sdiphosphate; o, phosphatidic acid; v, rest. 
of phosphatidyl-myo-inositol 4-phosphate and phos- 
phatidyl-myo-inositol 4,5-diphosphate in Ca2+-free 
medium containing EGTA. It appeared that in this 
medium only 20 or 10% of the radioactive phospha- 
tidyf-~yo-inositol 4,5~iphosphate or phosphatidyl- 
myo-inositoI4-phosphate was broken down after a 30 
min incubation period (Fig. 4). 
The effect of ACTHI_‘LO was tested because this 
peptide has been found to stimulate the formation of 
phosphatidyl-myo-inositol 4,5diphosphate in a lysed 
synaptosomal fraction in vitro in a Ca2+-sensitive way 
[9]. However, ACTH1_z4 did not affect the radioac- 
tive dephosphorylation in crude myelin or in the P2 
fraction at any incubation temperature tested (18, 
24, 30, 37°C). Likewise, no effects were found under 
Ca’+-free conditions or with normal (0.75 mM) or 
high (2.7 mM) Ca2+ concentrations (data not shown). 
Recovery of 32P, oio of zero mmtes lncu~atlorl 
125 10 20 30 
60 
A. 
125 10 20 30 
mm mubatton 
Fig. 3. Effect of incubation temperature on in vitro dephos- 
phory~iion of phosphatidyl-~yo-inositol 4-phosphate 
(lower) and phosphatidyI-boo-inositol $$diphosphate 
(upper). Phospholipid prelabeiling, preparation of the P2 
fraction and the incubation were performed as described 
(Fig. 2). The results are expressed as a percentage of the 
amount of radioactivity at the start of the incubationv , 0°C; 
*, 18°C; a, 24’0; a, 30°C; o, 37°C. 
Prelabelled phospholipids in purified synuptosomes, 
~ito~ho~dr~ and myelin 
In order to obtain more information on the exact 
location of the prelabelled phospholipids, synapto- 
somes were purified according to the method of 
Booth and Clark 2151. The synaptosomes prepared 
by this method are only slightly contaminated by free 
mitochondria (l-4%). Also mitochondria were puri- 
fied by this method and a myelin-enriched fraction 
was also obtained. Analysis of the lipid composition 
of the three fractions revealed that the synaptosomes 
and the mitochondria contained no cerebrosides and 
sulphatides (see Materials and Methods), indicating 
that they were devoid of myelin. As shown in Fig. 5, 
the phospholipid labeliing pattern in myelin, synapto- 
somes and n~ito~hondria was very different. The 
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L 125 10 20 30 
Incubation (mini 
Fig. 4. Effect of Ca2+ on the in vitro dephosphorylation of 
phosphatidyl-myo-inositol 4-phosphate (lower) and phospha- 
tidyl-myo-inositol4Jdiphosphate (upper). Phospholipid pre- 
labelling and the preparation of the crude synaptosomal frac- 
tion were performed as described (Fig. 2). The incubation 
was performed in medium without Ca2+ and with 1 mM 
added EGTA (*) or in standard medium containing 0.75 mM 
Ca2+ (0). The results are expressed as a percentage of the 
amount of radioactivity at the start of the incubation. 
PA 
CARDIOLIPIN 
Pp:: 
PS 
DPI 
TPI 
ORIGIN 
Fig. 5. Autoradiogram after extraction and thin-layer chro- 
matography of phospholipids after 2 h in vivo labelliig. a, 
myelin; b, synaptosomes; c, mitochondria. PS, phosphatidyl- 
serine; PE, phosphatidylethanolamine; PC, phosphatidylcho- 
line; PA, Phosphatidic acid; PI, phosphatidyl-myo-inositol; 
DPI, phosphatidyl-myo-inositol 4-phosphate; TPI, phospha- 
tidyl-myoinositol4Jdiphosphate. 
TABLE I 
INCORPORATION INTO PHOSPHOLIPIDS OF MYELIN, SYNAPTOSOMES AND MITOCHONDRIA 
Brain phospholipids were labelled in vivo for 2 h, and synaptosomes, mitochondria and myelin were purified as described in 
Materials and Methods. The incorporation is expressed as dpm per c(g protein (mean t SE.). Three different experiments gave 
similar results. 
Lipid class 
Phosphatidyl-myo-inositol 
Phosphatidyl-myo-inositol4-phosphate 
Phosphatidyl-myo-inositol4,5-diphosphate 
Phosphatidic acid 
Cardiolipin 
Phosphatidylserine 
Phosphatidylethanolamine 
Phosphatidylcholine 
Unidentified 
Total incorporation 
Incorporation (dpm/ng protein) 
Myelin Synaptosomes 
73 f 4 (6.1) 171 t 13 (19.5) 
149 f 9 (12.3) 147 + 9 (16.8) 
672 + 40 (55.5) 283 f 16 (32.3) 
135 + 3 (11.1) 62+ 5 (7.1) 
42f 5 (3.5) 66 + 3 (7.5) 
20f 2 (1.7) 305 4 (3.4) 
41 t 10 (3.4) 60 + 14 (6.9) 
36 f 3 (3.0) 44 + 4 (5.0) 
41+ 5 (3.4) 12+ 1 (1.4) 
1209 (100) 875 (100) 
Mitochondria 
262 t 29 (48.8) 
17t 4 (3.2) 
17 + 2 (3.2) 
28 f 2 (5.2) 
69 + 4 (12.9) 
9f 2 (1.7) 
70 t 12 (13.0) 
60 _+ 8 (11.2) 
5 t 1 (1.0) 
537 (100) 
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~tochond~a contained only very small amounts of 
radioactively labelled polyphosphoinositides (2.5% on 
a molar basis; Table I); The absolute amount of these 
lipids was so small that they could not be detected by 
the normal visualization techniques. High amounts of 
32P-labelled phosphatidyl-myo-inositol 4,.5-diphos- 
phate were present in myelin (52% of the total incor- 
poration); intermediate amounts of radioactively 
labelled phosphatidyl-myo-inositol 4-phosphate were 
found in both fractions (12% and 17% of the total 
incorporation, respectiveiy). A strikingly high amount 
of [32PJphosphatidyl~~~-inositol was present in 
mitochondria (49%). Therefore, the radioactively 
labefled phosphatidyl-~yu-inositol recovered from 
the P2 fraction (Fig. 1) may for a major part have 
been of mitochondrial origin. Radioactively labelled 
phosphatidic acid was recovered especially from mye- 
lin, and the specific mitochondrial phospholipid 
cardiolipin was recovered particularly from that frac- 
tion. The presence of radioactively labelled cardio- 
lipin in synaptosomes may be due to the intrasynap- 
tosomal mitochondria. 
When the prelabelled synaptosomes were incu- 
bated at 37°C in vitro, a rapid dephosphorylation of 
phosphatidyl~~~-inositol 4-phosphate and phospha- 
tidyl-~~Q-inositol 4,5&phosphate was observed that 
was similar to that found in the crude fractions. Like- 
wise, no change in phosphatidylmyo-inositol, phos- 
phatidic acid and the other phospholipids was ob- 
served. Similarly, the effects of Ca*+ and the lack of 
effect of ACTH1.24 were similar to those obtained in 
the P2 fraction (data not shown). 
Discussion 
The present study describes the in vivo labelling of 
rat brain phospholipids and their metabolism in vitro. 
The data obtained with the in vivo prelabelling tech- 
nique attract attention to the following points: 
First, the site of injection is a major determinant 
of the distribution of radioactivity over the brain. 
Using an intracisternal injection, Friedel et al. [22, 
231 found that the regional distribution was cere- 
bellum > brain stem > cerebral hemispheres. In the 
present study, however, after intracerebroventricular 
injection the regional distribution was Iimbic sys- 
tem > cerebral cortex > myelencephalon > cerebel- 
lum. In view of the relative abundance of polyphos- 
phoinositides in white matter, the route of adminis- 
tration of 32P determines the labelling pattern of the 
brain phospholipids. 
Second, in view of the rapid metabolism of poly- 
phosphoinositides both in vivo and in vitro (this 
study and Refs. 5, 9), studies on their metabolism in 
vivo must use a rapid tissue-fixation technique to 
prevent post-mortem degradation of the lipid. Our 
method of quick freezing in liquid nitrogen for 8 s, 
followed by rapid dissection of the coId but not 
frozen brain has some advantages over those rapid 
fixation techniques currently in use. The brain archi- 
tecture is not distorted, enabling the fast and accurate 
dissection of brain regions. Moreover, no enzyme 
denaturation occurs due to freezing and thawing. This 
enables the in vitro assay of membrane components 
after prelabelling in vivo and the comparison of dif- 
ferent subcellular fractions (see Fig. 5 and Table I). 
The present study describes the differential label- 
ling of membranes of myelin, synaptosomal or mito- 
chondrial origin (Fig. 5, Table I). The highly labelfed 
phosphatidyl-~~~-inosito1 4-phosphate and especially 
phosphatidyl-my~-inositol 4,5-diphosphate that were 
found in myelin support findings by others 124-261. 
Furthermore, highly labelled phospllatidyl-alto-inosi- 
toi 4-phosphate and phosphatidyl-myo-inositol 4,5- 
diphosphate were present in synaptosomes that were 
apparently devoid of myelin contamination as they 
did not contain cerebrosides and sulphatides. More 
phosphatidyl-myo-inositol4-phosphate was present in 
synaptosomal plasma membranes than myelin. This 
corroborates findings by others [3,4,27] and is in line 
with the findings that the phosphatidyl-Mao-inositol 
kinase is preferentially located in the plasma mem- 
brane [ZS]. The fact that highly labelled phospha- 
tidyl-m_yo-inositol was found in mitochondria may 
indicate that phosphatidyi-myo-inositoi-exchanging 
proteins [29J are active in vivo, as mitochondria lack 
the capacity to synthesize phosphatidyl-myo-inositol 
[3OJ. Furthermore, the absence of significant 
amounts of radioactively labelled phosphatidyl-myo- 
inositol 4-phosphate and phosphatidyl-myo-inositol 
4,5_diphosphate corroborates findings by others [31] 
that mitochondria lack the appropriate kinase activ- 
ity. The small amount of radioactively labelled phos- 
phatidyl-~y5-inositol 4-phosphate and pIlosphatidyl- 
myo-inositol 4,5~iphospllate found in mitochondria 
in the present study may be due to contamination by 
membranes of synaptosomal origin. 
In the present paper, the in vivo labelling tech- 
nique has been used to study polyphosphoinositide 
metabolism in vitro. A rapid and temperature-depen- 
dent loss of 32P from phosphatidyl-myo-inositol 
4-phosphate and phosphatidyl-myo-inositol 4,5di- 
phosphate was observed: the breakdown of phospha- 
tidyl-myo-inositol 4-phosphate and phosphatidyl- 
myo-inositol 4,5-diphosphate reached an asymptote 
at one-half and one-third of the original radioactivity, 
respectively. This decrease in phosphatidyl-myo-inosi- 
to1 4-phosphate and phosphatidyl-myo-inositol 4,5- 
diphosphate was not accompanied by an increase in 
radioactively labelled phosphatidyl-myo-inositol. The 
question arises as to what mechanism is involved in 
the observed breakdown of phosphatidyl-myo-inosi- 
to1 4-phosphate and phosphatidyl-myo-inositol4,5di- 
phosphate. As the incubation of synaptosomes in the 
medium described by Bradford [18] allows for oxy- 
dative phosphorylation, the presence of unlabelled 
ATP may result in the exchange of labelled mono- 
esterified [32P]phosphate for unlabelled phosphate. 
In that case the remaining radioactivity resides in the 
diesterified [32P]phosphate. One would have 
expected to find a breakdown of phosphatidyl-myo- 
inositol by phosphodiesterase activity, as seen in the 
agonist-induced phosphatidyl-myo-inositol response. 
However, it may be that under non-stimulated condi- 
tions this enzyme is much less active, as would appear 
from Fig. 2. More research is required to describe the 
route by which the breakdown of radioactive label 
goes in more detail. 
The presence of Ca2+ appeared of crucial impor- 
tance as polyphosphoinositide breakdown was inhib- 
ited greatly in the absence of this ion and in the pres- 
ence of EGTA (Fig. 4). However, although it has been 
reported that the phosphomonoesterases have an 
absolute requirement for Ca2+, the phosphodiester- 
ases are especially sensitive to this ion [32,33 1. Other 
studies on polyphosphoinositide metabolism in vitro 
after prelabelling in vivo also stress the important role 
of Ca2+ From experiments with neurotransmitters 
[7,8] and Ca2+ ionophore A23187 [6] it has been 
concluded that influx of Ca2+ stimulates the break- 
down of polyphosphoinositide at the cytoplasmic 
side of the plasma membrane. In these studies, the 
breakdown was performed by the combined action of 
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a phosphomonoesterase and a phosphodiesterase. 
The findings that half of the labile portion of 
radioactively labelled phosphatidyl-myo-inositol 
4-phosphate and phosphatidyl-myo-inositol 4,5di- 
phosphate was removed within 2 min is another indi- 
cation for the very rapid metabolism of these lipids 
[5,9]. These findings support the notion [9] that the 
conflicting evidence obtained in many previous stud- 
ies may be due to the long incubation periods used 
(lo-30 min). 
The present observation that ACTH1.2G is not 
effective under experimental conditions in which 
only radioactive dephosphorylation can be seen (this 
study) confirms previous reports [9] that its action is 
not on the polyphosphoinositide phosphatases but on 
the respective kinases. Likewise, the very rapid break- 
down of radioactively labelled phosphatidyl-myo-ino- 
sitol 4-phosphate and phosphatidyl-myo-inositol 4,5- 
diphosphate strengthens the observations that neuro- 
peptides affect polyphosphoinositide metabolism 
after very short incubation times [9 JO]. 
In conclusion, the reactivity of the polyphospho- 
inositides is manifested by their rapid and specific 
labelling in vivo and the fast breakdown of the radio- 
active label in vitro. The fact that highly labelled 
phosphatidylmyo-inositol 4-phosphate and phospha- 
tidyl-myo-inositol 4,5-diphosphate are found in puri- 
fied synaptosomes may point to their importance for 
synaptic function. 
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